SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-033389
Filing Date
2018-05-15
Accepted
2018-05-15 14:24:29
Documents
87
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8648_110q.htm 10-Q 1761385
2 EX-31.1 a18-8648_1ex31d1.htm EX-31.1 10087
3 EX-31.2 a18-8648_1ex31d2.htm EX-31.2 10094
4 EX-32.1 a18-8648_1ex32d1.htm EX-32.1 6101
5 EX-32.2 a18-8648_1ex32d2.htm EX-32.2 6100
  Complete submission text file 0001104659-18-033389.txt   10918430

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jagx-20180331.xml EX-101.INS 2324982
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jagx-20180331.xsd EX-101.SCH 115423
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jagx-20180331_cal.xml EX-101.CAL 78276
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jagx-20180331_def.xml EX-101.DEF 509501
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT jagx-20180331_lab.xml EX-101.LAB 847656
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jagx-20180331_pre.xml EX-101.PRE 709220
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 18835368
SIC: 2834 Pharmaceutical Preparations